Primary sclerosing cholangitis and inflammatory bowel disease: Intestine-liver interrelation.

Area of Science:

• Gastroenterology and Hepatology
• Immunology

Background:

• Primary sclerosing cholangitis (PSC) is a chronic liver disease often associated with inflammatory bowel disease (IBD).
• The co-occurrence of IBD and PSC suggests a shared pathophysiology and distinct clinical characteristics.
• This association presents unique challenges in management, including increased cancer risk and specific disease progression patterns.

Purpose of the Study:

• To review the distinct clinical entity of the association between IBD and PSC.
• To elucidate the influence of IBD on the progression, transplantation needs, and recurrence of PSC.
• To discuss current evidence regarding biological therapies for patients with IBD and PSC.

Main Methods:

• Literature review of studies investigating the association between IBD and PSC.
• Analysis of genetic, epidemiological, endoscopic, and histological data.
• Evaluation of outcomes including cancer risk, transplantation, and recurrence.
• Review of clinical trial data on biological therapies.

Main Results:

• The IBD-PSC association exhibits specific features: genetic factors, male predominance, right colon inflammation, backwash ileitis, and rectal sparing.
• Patients with IBD-PSC have an elevated risk of colorectal cancer and cholangiocarcinoma.
• IBD significantly impacts PSC progression, transplantation requirements, and recurrence rates.

Conclusions:

• The IBD-PSC association is a distinct clinical entity requiring tailored management strategies.
• Understanding the interplay between IBD and PSC is crucial for optimizing patient outcomes and treatment decisions.
• Further research into biological therapies is warranted for this patient population.